MacroGenics
(NASDAQ) MGNX
MacroGenics Financials at a Glance
Market Cap
$185.58M
Revenue (TTM)
$149.50M
Net Income (TTM)
$74.62M
EPS (TTM)
$-1.18
P/E Ratio
-2.47
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$2.73
Volume
30,720
Open
$2.86
Price
$2.73
Volume
30,720
Open
$2.86
Previous Close
$2.73
Daily Range
$2.72 - $2.86
52-Week Range
$0.99 - $3.54
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$2.73
Volume
30,720
Open
$2.86
Previous Close
$2.73
Daily Range
$2.72 - $2.86
52-Week Range
$0.99 - $3.54
MGNX News
Why MacroGenics Stock Tumbled Today
MGNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MacroGenics
Industry
Biotechnology
Sector
Health CareEmployees
293
CEO
Eric Risser, MBA
Website
www.macrogenics.comHeadquarters
Rockville, MD 20850, US
MGNX Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
-49%
Net Income Margin
-50%
Return on Equity
-87%
Return on Capital
-34%
Return on Assets
-29%
Earnings Yield
-40.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$185.58M
Shares Outstanding
63.56M
Volume
30.72K
Short Interest
0.00%
Avg. Volume
1.11M
Financials (TTM)
Gross Profit
$106.32M
Operating Income
$72.84M
EBITDA
$65.67M
Operating Cash Flow
$81.04M
Capital Expenditure
$1.91M
Free Cash Flow
$82.95M
Cash & ST Invst.
$189.91M
Total Debt
$106.76M
MacroGenics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$41.23M
+132.5%
Gross Profit
$25.73M
+110.2%
Gross Margin
62.41%
N/A
Market Cap
$185.58M
N/A
Market Cap/Employee
$544.23K
N/A
Employees
341
N/A
Net Income
$14.15M
+8.2%
EBITDA
$15.01M
-20.6%
Quarterly Fundamentals
Net Cash
$83.15M
-49.4%
Accounts Receivable
$13.37M
+210.4%
Inventory
$7.91M
N/A
Long Term Debt
$101.58M
+211.6%
Short Term Debt
$5.18M
+6.4%
Return on Assets
-29.05%
N/A
Return on Invested Capital
-34.08%
N/A
Free Cash Flow
$42.78M
+209.6%
Operating Cash Flow
$43.02M
+212.0%